Organ Transplant Immunosuppressant Drugs Market

Mar 2021| MRS112A| Market Research Studies

Report Highlights

The scope of this report broadly covers different types of organ transplant immunosuppressant drugs on the basis of their drug class. The Organ Transplant Immunosuppressant Drugs Market is mainly segregated on the basis of by drug class, by transplant organ, by type, by distribution channel, by region, and by company. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each type, origin, application, end-user, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Organ Transplant Immunosuppressant Drugs Markets; it explains the major market drivers of the Global Organ Transplant Immunosuppressant Drugs industry, current trends within the industry, major applications and the regional dynamics of the Global Organ Transplant Immunosuppressant Drugs Market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Organ Transplant Immunosuppressant Drugs Market.

Report Includes

  • 46 tables and 54 figures
  • An up-to-date analysis of the Global Organ Transplant Immunosuppressant Drugs Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Organ Transplant Immunosuppressant Drugs Market, and corresponding market share analysis by drug class, transplant organ, type, distribution channel, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Organ Transplant Immunosuppressant Drugs, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new drugs still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Organ Transplant Immunosuppressant Drugs Market as compared to overall global economy.
  • Insight into the growth development strategies of major Organ Transplant Immunosuppressant Drugs manufacturers and their key competitive landscape.
  • Descriptive company profiles of the leading market participants, including Astellas Pharma, Inc., Sanofi S.A., Intas Pharmaceuticals Limited, Novartis International AG, Dr. Reddy’s Laboratories Ltd., and others.

Summary

Organ Transplant is a procedure required in cases of organ failure. During this procedure, the organ is removed from the donor’s body and is placed into the body of the recipient. There are huge changes that the recipient often rejects the organ transplant in a way that the body creates an immune response towards the transplant organ which could further lead to transplant failure. In order to reduce the possibility of transplant failure, immunosuppressant drugs are given to determine the compatibility of the donor and recipient.

The Organ Transplant Immunosuppressant Drugs Market is fragmented on the basis of drug class, transplant organ, type and distribution channel. Based on transplant organ, the market is further segmented into heart, kidney, lung, liver, and others. Among these, kidney transplant dominated the transplant market and is expected to maintain its position in the coming years as well. This can be attributed to cost-effective kidney transplant procedure than the extended dialysis sessions.

The Global Organ Transplant Immunosuppressant Drugs Market was valued at $4.83 billion in 2020 and is expected to witness a CAGR of 3.5% in the next 5 years.

  • Table 1 : Global Organ Transplant Immunosuppressant Drugs Market, Through 2026
  • Table 2 : Global Organ Transplant Immunosuppressant Drugs Market, by Drug Class, Through 2026
  • Table 3 : Global Organ Transplant Immunosuppressant Drugs Market, by Transplant Organ, Through 2026
  • Table 4 : Global Organ Transplant Immunosuppressant Drugs Market, by Type, Through 2026
  • Table 5 : Global Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, Through 2026
  • Table 6 : Global Organ Transplant Immunosuppressant Drugs Market, by Region, Through 2026
  • Table 7 : North America Organ Transplant Immunosuppressant Drugs Market, by Drug Class, Through 2026
  • Table 8 : North America Organ Transplant Immunosuppressant Drugs Market, by Transplant Organ, Through 2026
  • Table 9 : North America Organ Transplant Immunosuppressant Drugs Market, by Type, Through 2026
  • Table 10 : North America Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, Through 2026
  • Table 11 : North America Organ Transplant Immunosuppressant Drugs Market, by Country, Through 2026
  • Table 12 : Europe Organ Transplant Immunosuppressant Drugs Market, by Drug Class, Through 2026
  • Table 13 : Europe Organ Transplant Immunosuppressant Drugs Market, by Transplant Organ, Through 2026
  • Table 14 : Europe Organ Transplant Immunosuppressant Drugs Market, by Type, Through 2026
  • Table 15 : Europe Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, Through 2026
  • Table 16 : Europe Organ Transplant Immunosuppressant Drugs Market, by Country, Through 2026
  • Table 17 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Drug Class, Through 2026
  • Table 18 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Transplant Organ, Through 2026
  • Table 19 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Type, Through 2026
  • Table 20 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, Through 2026
  • Table 21 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Country, Through 2026
  • Table 22 : South America Organ Transplant Immunosuppressant Drugs Market, by Drug Class, Through 2026
  • Table 23 : South America Organ Transplant Immunosuppressant Drugs Market, by Transplant Organ, Through 2026
  • Table 24 : South America Organ Transplant Immunosuppressant Drugs Market, by Type, Through 2026
  • Table 25 : South America Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, Through 2026
  • Table 26 : South America Organ Transplant Immunosuppressant Drugs Market, by Country, Through 2026
  • Table 27 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Drug Class, Through 2026
  • Table 28 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Transplant Organ, Through 2026
  • Table 29 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Type, Through 2026
  • Table 30 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, Through 2026
  • Table 31 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Country, Through 2026
  • Table 32 : Astellas Pharma, Inc.: Financial Performance, Through 2020
  • Table 33 : Sanofi S.A.: Financial Performance, Through 2020
  • Table 34 : Intas Pharmaceuticals Limited: Financial Performance, Through 2020
  • Table 35 : Novartis International AG: Financial Performance, Through 2020
  • Table 36 : Dr. Reddy’s Laboratories Ltd.: Financial Performance, Through 2020
  • Table 37 : F. Hoffmann-La Roche AG: Financial Performance, Through 2020
  • Table 38 : Veloxis Pharmaceuticals A/S: Financial Performance, Through 2020
  • Table 39 : Bristol-Myers Squibb Company: Financial Performance, Through 2020
  • Table 40 : AbbVie Inc.: Financial Performance, Through 2020
  • Table 41 : Biocon Ltd.: Financial Performance, Through 2020
  • Table 42 : Cadila Healthcare Ltd.: Financial Performance, Through 2020
  • Table 43 : Neovii Pharmaceuticals AG: Financial Performance, Through 2020
  • Table 44 : Belcher Pharmaceuticals LLC: Financial Performance, Through 2020
  • Table 45 : Panacea Biotec Ltd.: Financial Performance, Through 2020
  • Table 46 : Glenmark Pharmaceuticals Ltd.: Financial Performance, Through 2020
  • Figure 1 : Global Organ Transplant Immunosuppressant Drugs Market
  • Figure 2 : Global Organ Transplant Immunosuppressant Drugs Market, by Value, 2019-2026
  • Figure 3 : Global Organ Transplant Immunosuppressant Drugs Market, by Value, by Drug Class, 2019-2026
  • Figure 4 : Global Organ Transplant Immunosuppressant Drugs Market, by Value, by Transplant Organ, 2019-2026
  • Figure 5 : Global Organ Transplant Immunosuppressant Drugs Market, by Value, by Type, 2019-2026
  • Figure 6 : Global Organ Transplant Immunosuppressant Drugs Market, by Value, by Distribution Channel, 2019-2026
  • Figure 7 : Global Organ Transplant Immunosuppressant Drugs Market, by Value, by Region, 2020
  • Figure 8 : Global Organ Transplant Immunosuppressant Drugs Market, by Value, by Company, 2020
  • Figure 9 : Global Organ Transplant Immunosuppressant Drugs Market, Product Map, 2020
  • Figure 10 : North America Organ Transplant Immunosuppressant Drugs Market, by Value, 2019-2026
  • Figure 11 : North America Organ Transplant Immunosuppressant Drugs Market, by Value, by Drug Class, 2019-2026
  • Figure 12 : North America Organ Transplant Immunosuppressant Drugs Market, by Value, by Transplant Organ, 2019-2026
  • Figure 13 : North America Organ Transplant Immunosuppressant Drugs Market, by Value, by Type, 2019-2026
  • Figure 14 : North America Organ Transplant Immunosuppressant Drugs Market, by Value, by Distribution Channel, 2019-2026
  • Figure 15 : North America Organ Transplant Immunosuppressant Drugs Market, by Value, by Country, 2020
  • Figure 16 : Europe Organ Transplant Immunosuppressant Drugs Market, by Value, 2019-2026
  • Figure 17 : Europe Organ Transplant Immunosuppressant Drugs Market, by Value, by Drug Class, 2019-2026
  • Figure 18 : Europe Organ Transplant Immunosuppressant Drugs Market, by Value, by Transplant Organ, 2019-2026
  • Figure 19 : Europe Organ Transplant Immunosuppressant Drugs Market, by Value, by Type, 2019-2026
  • Figure 20 : Europe Organ Transplant Immunosuppressant Drugs Market, by Value, by Distribution Channel, 2019-2026
  • Figure 21 : Europe Organ Transplant Immunosuppressant Drugs Market, by Value, by Country, 2020
  • Figure 22 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Value, 2019-2026
  • Figure 23 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Value, by Drug Class, 2019-2026
  • Figure 24 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Value, by Transplant Organ, 2019-2026
  • Figure 25 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Value, by Type, 2019-2026
  • Figure 26 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Value, by Distribution Channel, 2019-2026
  • Figure 27 : Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, by Value, by Country, 2020
  • Figure 28 : South America Organ Transplant Immunosuppressant Drugs Market, by Value, 2019-2026
  • Figure 29 : South America Organ Transplant Immunosuppressant Drugs Market, by Value, by Drug Class, 2019-2026
  • Figure 30 : South America Organ Transplant Immunosuppressant Drugs Market, by Value, by Transplant Organ, 2019-2026
  • Figure 31 : South America Organ Transplant Immunosuppressant Drugs Market, by Value, by Type, 2019-2026
  • Figure 32 : South America Organ Transplant Immunosuppressant Drugs Market, by Value, by Distribution Channel, 2019-2026
  • Figure 33 : South America Organ Transplant Immunosuppressant Drugs Market, by Value, by Country, 2020
  • Figure 34 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Value, 2019-2026
  • Figure 35 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Value, by Drug Class, 2019-2026
  • Figure 36 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Value, by Transplant Organ, 2019-2026
  • Figure 37 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Value, by Type, 2019-2026
  • Figure 38 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Value, by Distribution Channel, 2019-2026
  • Figure 39 : Middle East & Africa Organ Transplant Immunosuppressant Drugs Market, by Value, by Country, 2020
  • Figure 40 : Astellas Pharma, Inc.: Revenue Share, 2020
  • Figure 41 : Sanofi S.A.: Revenue Share, 2020
  • Figure 42 : Intas Pharmaceuticals Limited: Revenue Share, 2020
  • Figure 43 : Novartis International AG: Revenue Share, 2020
  • Figure 44 : Dr. Reddy’s Laboratories Ltd.: Revenue Share, 2020
  • Figure 45 : F. Hoffmann-La Roche AG: Revenue Share, 2020
  • Figure 46 : Veloxis Pharmaceuticals A/S: Revenue Share, 2020
  • Figure 47 : Bristol-Myers Squibb Company: Revenue Share, 2020
  • Figure 48 : AbbVie Inc.: Revenue Share, 2020
  • Figure 49 : Biocon Ltd.: Revenue Share, 2020
  • Figure 50 : Cadila Healthcare Ltd.: Revenue Share, 2020
  • Figure 51 : Neovii Pharmaceuticals AG: Revenue Share, 2020
  • Figure 52 : Belcher Pharmaceuticals LLC: Revenue Share, 2020
  • Figure 53 : Panacea Biotec Ltd.: Revenue Share, 2020
  • Figure 54 : Glenmark Pharmaceuticals Ltd.: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report